Neuroscience research reveals new insights into Alzheimer's and Parkinson's

Researchers have made significant advancements in understanding the mechanisms behind neurodegenerative diseases such as Alzheimer's and Parkinson's.

A study published in the journal Nature by an international team, including scientists from the MRC Molecular Biology Laboratory in the UK and institutions in Japan, has provided atomic-level evidence that defective proteins spread through the brain similarly to prions. The research demonstrates that different “strains” of tau proteins, which are responsible for various tauopathies, maintain their specific three-dimensional structures when transmitted between brains. This confirms that these proteins act as templates, forcing healthy proteins to adopt the same abnormal shape.

In a separate study published in the journal Brain, researchers led by the University of Birmingham identified a potential target to reduce brain inflammation. By blocking the P2X7 receptor, scientists significantly decreased inflammatory responses in human cell cultures and brain tissue. This receptor is linked to the release of cytokines, specifically interleukin-1 beta (IL-1β). This discovery offers a potential pathway for developing therapies to treat neuroinflammation associated with Alzheimer's, Parkinson's, multiple sclerosis, and other neurological conditions.